Connor, Clark & Lunn Investment Management (CC&L)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.8M | Buy |
|
|||||
|
2025
Q1 | $28.1M | Buy |
|
|||||
|
2024
Q4 | $22.6M | Sell |
|
|||||
|
2024
Q3 | $51.4M | Buy |
|
|||||
|
2024
Q2 | $49.3M | Buy |
|
|||||
|
2024
Q1 | $38.6M | Sell |
|
|||||
|
2023
Q4 | $37.9M | Sell |
|
|||||
|
2023
Q3 | $59.5M | Buy |
|
|||||
|
2023
Q2 | $5.89M | Sell |
|
|||||
|
2023
Q1 | $13.5M | Sell |
|
|||||
|
2022
Q4 | $23M | Sell |
|
|||||
|
2022
Q3 | $23.7M | Sell |
|
|||||
|
2022
Q2 | $62M | Sell |
|
|||||
|
2022
Q1 | $59.3M | Buy |
|
|||||
|
2021
Q4 | $32M | Sell |
|
|||||
|
2021
Q3 | $36.3M | Sell |
|
|||||
|
2021
Q2 | $42.5M | Sell |
|
|||||
|
2021
Q1 | $44.7M | Buy |
|
|||||
|
2020
Q4 | $14.2M | Sell |
|
|||||
|
2020
Q3 | $27.1M | Buy |
|
|||||
|
2020
Q2 | $14M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $10M | Sell |
|
|||||
|
2019
Q3 | $33.3M | Sell |
|
|||||
|
2019
Q2 | $41.3M | Buy |
|
|||||
|
2019
Q1 | $25.7M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $7.16M | Buy |
|
|||||
|
2017
Q4 | $5.69M | Sell |
|
|||||
|
2017
Q3 | $6.79M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $3.45M | Sell |
|
|||||
|
2015
Q4 | $7.33M | Buy |
|
|||||
|
2015
Q3 | $5M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $2.99M | Sell |
|
|||||
|
2014
Q4 | $2.96M | Sell |
|
|||||
|
2014
Q3 | $3.8M | Buy |
|
|||||
|
2014
Q2 | $2.89M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $7.95M | Buy |
|
|||||
|
2013
Q3 | $5.21M | Buy |
|
|||||
|
2013
Q2 | $4.02M | Buy |
|